We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · April 02, 2021

Effectiveness of Secukinumab in the Treatment of Moderate to Severe Hidradenitis Suppurativa

Journal of the European Academy of Dermatology and Venereology: JEADV

 

Additional Info

Journal of the European Academy of Dermatology and Venereology: JEADV
Effectiveness of Secukinumab in the Treatment of Moderate-Severe Hidradenitis Suppurativa: Results From an Italian Multicentric Retrospective Study in a Real-Life Setting
J Eur Acad Dermatol Venereol 2021 Feb 16;[EPub Ahead of Print], S Ribero, A Ramondetta, G Fabbrocini, V Bettoli, C Potenza, A Chiricozzi, M Licciardello, AV Marzano, L Bianchi, G Rozzo, L Fania, C Marasca, G Odorici, A Mambrin, C Moltrasio, RD Caposiena Caro, N Skroza, P Quaglino, N Siliquini, P Dapavo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading